Carlton-Harvey Group
Consulting and private investment firm focused on early-stage and growth-challenged medical device companies. Offers advisory services in product development, commercialization, go-to-market and international sales, funding (equity and debt) and acquisition strategies, with experience in regulatory remediation and interim management.
Industries
Nr. of Employees
small (1-50)
Carlton-Harvey Group
Services
Customized consulting across funding strategies, acquisition strategy, strategic direction, regulatory remediation, commercialization, go-to-market, and international sales.
Equity and debt funding for micro to small-cap medical device companies, with potential for hands-on management involvement.
Customized consulting across funding strategies, acquisition strategy, strategic direction, regulatory remediation, commercialization, go-to-market, and international sales.
Equity and debt funding for micro to small-cap medical device companies, with potential for hands-on management involvement.
Expertise Areas
- Medical device commercialization
- Go-to-market and international sales
- Funding and investment for early-stage device companies
- Regulatory strategy and remediation (including FDA)
Key Technologies
- Medical device product development
- Market access and reimbursement strategy
- Regulatory compliance and remediation
- Commercialization and go-to-market planning
News & Updates
Announcement of a strategic equity investment and assumption of management control of a medical device company producing a patient mobility solution. Carlton-Harvey Group principals took executive roles as part of the transaction.
Announcement of a strategic equity investment and assumption of management control of a medical device company producing a patient mobility solution. Carlton-Harvey Group principals took executive roles as part of the transaction.